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To the Editor: The value of inpatient dermatology consultation is well established and 43 
presumably reflects execution of the consultant’s recommendations. At many institutions, 44 
dermatologists performing hospital consultations rely on the primary team to implement 45 
recommendations. Adherence has been an active area of research in numerous medical 46 
specialties, but the existing data within dermatology is limited.1-3 This study describes overall 47 
adherence with the consulting team’s recommendations and investigates how recommendation 48 
characteristics relate to adherence.   49 
     We performed a retrospective chart review of all inpatient dermatology consultations from 50 
March 1, 2012-March 31, 2017 at University of Kentucky Medical Center (Lexington, Kentucky, 51 
USA). Primary team adherence with the consulting dermatologist’s recommendations was 52 
determined based on the presence of an order in the medical record.  53 
    417 consultations for 393 patients were included for analysis. Patients were 52% (n=206) male 54 
and 82% (n=323) non-Hispanic white. Full adherence was achieved for 48.4% (202/417) of 55 
consultations (i.e. all recommendations from the consultation had full adherence) and for 67.4% 56 
(595/883) of recommendations.  When using each recommendation as a unit, a higher number of 57 
recommendations per consultation was associated with higher full adherence (P< 0.001) and 58 
lower nonadherence (P = 0.004). Diagnostic recommendations had higher full adherence than 59 
therapeutic recommendations (84.0% vs. 65.2%, P < 0.001), and recommendations to 60 
discontinue or continue therapies had high full adherence (Table I). 61 
     77% (n=677) of recommendations were for initiation of a new treatment. Topical therapies 62 
had lower full adherence rates (54.0% vs. 74.3%, P < 0.001), higher rates of modification (18.4% 63 
vs. 11.2%, P = 0.025), and higher rates of nonadherence (27.7% vs 14.5%, P < 0.001) compared 64 
to systemic therapies. Topical steroids were the most common recommendation overall and 65 
compared to systemic steroids had lower full adherence (52.1% vs. 75.0%, P < 0.001) and higher 66 
nonadherence (25.9% vs. 12.5%, P = 0.025). The same pattern was seen for antimicrobials but 67 
the differences were not statistically significant (Table II).  68 
    The 67.4% full adherence rate in our study is lower than previously reported rates of 70% to 69 
93%.1-3 Similar to our study, previous studies of hospital dermatology consultations have found 70 
topical treatments account for the majority of recommendations, with topical steroids as the most 71 
common recommendation overall.3,4 Accordingly, it is notable that our study found 72 
nonadherence for topical therapies overall (27.7% vs. 14.5%) and topical steroids (25.9% vs. 73 
12.5%) were approximately double that of their systemic counterparts. There is evidence that 74 
patient adherence with topical treatment is inferior to oral treatment in the outpatient setting; 75 
however, the reason for healthcare provider nonadherence requires further investigation.5 76 
     Limitations include lack of data regarding rationale for nonadherence, consequences of 77 
nonadherence, or differences in adherence based on severity of dermatologic disease.  78 
Awareness of recommendations with low adherence will allow the consulting dermatologist to 79 
monitor accordingly, investigate the rationale for nonadherence, and offer alternative treatment 80 
plans when appropriate.  Future studies should focus on confirming inferior adherence for topical 81 
therapies, assessing the impact of adherence on patient outcome, and investigating strategies to 82 











Table I. Adherence by recommendation type 
 No. (%) of recommendations 
 Full adherence* Adherence with 
modification† 
Nonadherence‡ 
Recommendation category    
   All recommendations 595 (67.4) 109 (12.3) 179 (20.3) 
      Therapeutic  505 (65.2) 109 (14.1) 161 (20.8) 
      Diagnostic  84 (84.0) 0 (0) 16 (16.0) 
      Consultation  6 (75.0) 0 (0) 2 (25.0) 
Therapeutic 
recommendations 
   
   Initiate  409 (60.4) 109 (16.1) 159 (23.5) 
   Continue  63 (96.9) 0 (0) 2 (3.1) 
   Discontinue  33 (100) 0 (0) 0 (0) 
Total number of 
recommendations 
   
   1 97 (55.7) 34 (19.5) 43 (24.7) 
   2-3 295 (65.8) 52 (11.6) 101 (22.5) 
   ≥ 4 203 (77.8) 23 (8.8) 35 (13.4) 
* Order appears exactly as recommended 94 
† Modification to the dosing (potency, vehicle, or schedule) or use of a different medication in the same class with 95 
the same therapeutic purpose 96 




Table II. Initiation of topical and systemic therapies 
 No. (%) of recommendations 
 Full adherence Adherence with 
modification 
Nonadherence 
Overall    
     Topical  250 (54.0) 85 (18.4) 128 (27.7) 
     Systemic  159 (74.3) 24 (11.2)  31(14.5)  
Steroids    
     Topical  147 (52.1) 62 (22.0) 73 (25.9) 
     Systemic  54 (75.0) 9 (12.5) 9 (12.5) 
Antimicrobials    
     Topical  50 (56.8) 18 (20.5) 20 (22.7) 
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